Advantages of nanotechnology- based Chinese herb drugs on biological activities

Current Drug Metabolism

Volumn 10, Issue 8, 2009, Pages 905-913

  Huang, Sherry ^a   Chang, Walter H ^a  

^a CHUNG YUAN CHRISTIAN UNIVERSITY   (Taiwan)

Author keywords

Chinese herb drug; Drug carrier; Nanoparticles; Nanotechnology; Target

Indexed keywords

10 HYDROXYCAMPTOTHECIN; 10 METHOXY 9 NITROCAMPTOTHECIN; 9 NITRO 20 CAMPTOTHECIN; ANTINEOPLASTIC AGENT; ASIATICOSIDE; BREVISCAPINE; CALAMINE; CAMPTOTHECIN; CUSCUTA CHINENSIS EXTRACT; DAIDZEIN; FLAVONOID; GLYCEROL BEHENATE; GLYCYRRHIZIC ACID; HYPERICIN; IRINOTECAN; MACROGOL; NANOPARTICLE; NARINGENIN; ORIDONIN; PHOSPHATIDYLCHOLINE; PLANT EXTRACT; POLOXAMER; POLYLACTIC ACID; REALGAR; RUBITECAN; SILYMARIN; TETRANDRINE; TOPOTECAN; TRIPTOLIDE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIVIRAL ACTIVITY; BIOLOGICAL ACTIVITY; BURN; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; CHINESE HERB; COLORECTAL CANCER; CUSCUTA; CYTOTOXICITY; DRUG ABSORPTION; DRUG ACTIVITY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG HALF LIFE; DRUG SOLUBILITY; DRUG STRUCTURE; ERIGERON; HUMAN; INJURY; KIDNEY DISEASE; LIVER DISEASE; LIVER PROTECTION; NANOTECHNOLOGY; NONHUMAN; OVARY CANCER; PARTICLE SIZE; PHOTODYNAMIC THERAPY; REVIEW; SALVIA MILTIORRHIZA; SILYBUM MARIANUM; STEADY STATE; TRADITIONAL MEDICINE; WOUND HEALING;

ANIMALS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRUG EVALUATION, PRECLINICAL; DRUGS, CHINESE HERBAL; HUMANS; MOLECULAR STRUCTURE; NANOPARTICLES; NANOTECHNOLOGY; PARTICLE SIZE; TECHNOLOGY, PHARMACEUTICAL;

EID: 74249096803     PISSN: 13892002     EISSN: None     Source Type: Journal    
DOI: 10.2174/138920009790274603     Document Type: Review

References (75)

1. Qiu, D.; Kao, P. N. Immunosuppressive and anti-inflammatory mechanisms of triptolide, the principal active diterpenoid from the Chinese medicinal herb Tripterygium wilfordii Hook. f. Drugs R. D, 2003, 4(1), 1-18.
2. Nan, J. X.; Park, E. J.; Kim, Y. C.; Ko, G.; Sohn, D. H. Scutellaria baicalensis inhibits liver fibrosis induced by bile duct ligation or carbon tetrachloride in rats. J. Pharm. Pharmacol., 2002, 54(4), 555-563.
3. Li, X. K.; Motwani, M.; Tong, W.; Bornmann, W.; Schwartz, G. K. Huanglian, A chinese herbal extract, inhibits cell growth by suppressing the expression of cyclin B1 and inhibiting CDC2 kinase activity in human cancer cells. Mol. Pharmacol., 2000, 58(6), 1287-1293.
4. Bottex-Gauthier, C.; Vidal, D.; Picot, F.; Potier, P.; Menichini, F.; Appendino, G. In vitro biological activities of arglabin, a sesquiterpene lactone from the Chinese herb Artemisia myriantha Wall.(Asteraceae). Biotechnol. Ther., 1993, 4(1-2), 77-98.
5. Chen, P. M.; Hsiao, K. I.; Su, J. L.; Liu, J.; Yang, L. L. Study of the activities of Chinese herb Viscum alniformosanae Part II: The components of conditioned medium produced by Viscum alniformosanae-stimulated mononuclear cells. Am. J. Chin. Med., 1992, 20(3-4), 307-312.
6. Yang, L. L.; Hsiao, K. I.; Su, J. L.; Liu, J.; Chen, P. M. Study of the activity of differentiation-induction in a Chinese herb-viscum alniformosanae. Part 1: In vitro induction of differentiation in HL-60 leukemic cell line by conditioned medium secreted from viscum alniformosanae-stimulated mononuclear cells. Am. J. Chin. Med., 1991, 19(1), 33-39.
7. Chu, D. T.; Lepe-Zuniga, J.; Wong, W. L.; LaPushin, R.; Mavligit, G. M. Fractionated extract of Astragalus membranaceus, a Chinese medicinal herb, potentiates LAK cell cytotoxicity generated by a low dose of recombinant interleukin-2. J. Clin. Lab. Immunol., 1988, 26(4), 183-187.
8. Kawakita, T.; Yamada, A.; Kumazawa, Y.; Nomoto, K. Accumulation of immature B and null lymphocytes in the periphery after intraperitoneal administration of traditional Chinese medicine, xiao-chai-hu-tang(Japanese name: shosaiko-to). J. Immunopharmacol., 1986, 8(4), 561-588.
9. Liu, M.; Li, Y.; Chou, G.; Cheng, X.; Zhang, M.; Wang, Z. Extraction and ultra-performance liquid chromatography of hydrophilic and lipophilic bioactive components in a Chinese herb Radix Salviae Miltiorrhizae. J. Chromatogr. A, 2007, 1157(1-2), 51-55.
10. Zuo, X. J.; Okada, Y.; Toyoda, M.; Yap, H. K.; Marchevsky, A.; Matloff, J. M.; Jordan, S. C. Hydrophobic extracts of a Chinese herb(CMX-13) exhibit potent immunosuppressive properties and prevent acute rejection in a highly histoincompatible model of rat lung transplantation. Transplantation, 2000, 70(7), 1094-1098.
11. Yap, H. K.; Zuo, X. J.; Toyoda, M.; Okada, Y.; Ang, S. G.; Lai, Y. H.; Matloff, J. M.; Marchevsky, A.; Ramgolam, V. S.; Jordan, S. C. Immunosuppressive effect of the hydrophobic extract of a Chinese herb on rat lung allograft rejection. Transplant. Proc., 1998, 30(4), 980-981.
12. Tinke, A. P.; Vanhoutte, K.; De Maesschalck, R.; Verheyen, S.; De Winter, H. A new approach in the prediction of the dissolution behavior of suspended particles by means of their particle size distribution. J. Pharm. Biomed. Anal., 2005, 39(5), 900-907.
13. Rinaki, E.; Dokoumetzidis, A.; Macheras, P. The mean dissolution time depends on the dose/solubility ratio. Pharm. Res., 2003, 20(3), 406-408.
14. Jinno, J.; Kamada, N.; Miyake, M.; Yamada, K.; Mukai, T.; Odomi, M.; Toguchi, H.; Liversidge, G. G.; Higaki, K.; Kimura, T. Effect of particle size reduction on dissolution and oral absorption of a poorly water-soluble drug, cilostazol, in beagle dogs. J. Control. Release, 2006, 111(1-2), 56-64.
15. Wong, T. S.; Brough, B.; Ho, C. M. Creation of functional micro/nano systems through top-down and bottom-up approaches. Mol. Cell Biomech., 2009, 6(1), 1-55.
16. Farokhzad, O. C.; Langer, R. Impact of nanotechnology on drug delivery. ACS Nano., 2009, 3(1), 16-20.
17. Cheng, J. Y.; Mayes, A. M.; Ross, C. A. Nanostructure engineering by templated self-assembly of block copolymers. Nat. Mater., 2004, 3(11), 823-828.
18. Lazzari, M.; Rodriguez-Abreu, C.; Rivas, J.; Lopez-Quintela, M. A. Self-assembly: a minimalist route to the fabrication of nanomaterials. J. Nanosci. Nanotechnol., 2006, 6(4), 892-905.
19. Zou, J. H.; Shi, W. F.; Wang, J.; Jun, B. Encapsulation and controlled release of a hydrophobic drug using a novel nanoparticle-forming hyperbranched polyester. Macromol. Biosci., 2005, 5(7), 662-668.
20. Gao, Y.; Gu, W. W.; Chen, L. L.; Xu, Z. H.; Li, Y. P. The role of daidzein-loaded sterically stabilized solid lipid nanoparticles in therapy for cardio-cerebrovascular diseases. Biomaterials, 2008, 29(30), 4129-4136.
21. Yen, F. L.; Wu, T. H.; Lin, L. T.; Cham, T. M.; Lin, C. C. Naringenin-Loaded Nanoparticles Improve the Physicochemical Properties and the Hepatoprotective Effects of Naringenin in Orally-Administered Rats with CCl4-Induced Acute Liver Failure. Pharm. Res., 2009, 26(4), 893-902.
22. He, J.; Hou, S. X.; Lu, W. G.; Zhu, L.; Feng, J. F. Preparation, pharmacokinetics and body distribution of silymarin-loaded solid lipid nanoparticles after oral administration. J. Biomed. Nanotechnol., 2007, 3(2), 195-202.
23. Liu, M.; Li, H.; Luo, G.; Liu, Q.; Wang, Y. Pharmacokinetics and biodistribution of surface modification polymeric nanoparticles. Arch. Pharm. Res., 2008, 31(4), 547-554. [24] Yen, F. L.; Wu, T. H.; Lin, L. T.; Cham, T. M.; Lin, C. C. Concordance between antioxidant activities and flavonol contents in different extracts and fractions of Cuscuta chinensis. Food Chem., 2008, 108(2), 455-462.
24. Yen, F. L.; Wu, T. H.; Lin, L. T.; Lin, C. C. Hepatoprotective and antioxidant effects of Cuscuta chinensis against acetaminopheninduced hepatotoxicity in rats. J. Ethnopharmacol., 2007, 111(1), 123-128.
25. Umehara, K.; Nemoto, K.; Ohkubo, T.; Miyase, T.; Degawa, M.; Noguchi, H. Isolation of a new 15-membered macrocyclic glycolipid lactone, cuscutic resinoside a from the seeds of Cuscuta chinensis: A stimulator of breast cancer cell proliferation. Planta Med., 2004, 70(4), 299-304.
26. Yen, F. L.; Wu, T. H.; Lin, L. T.; Cham, T. M.; Lin, C. C. Nanoparticles formulation of Cuscuta chinensis prevents acetaminophen-induced hepatotoxicity in rats. Food Chem. Toxicol., 2008, 46(5), 1771-1777.
27. Loch-Neckel, G.; Nemen, D.; Puhl, A. C.; Fernandes, D.; Stimarniglio, M. A.; Silva, M. A.; Hangai, M.; Silva, M. C. S.; Lemos-Senna, E. Stealth and non-stealth nanocapsules containing camptothecin: In-vitro and in-vivo activity on B16-F10 melanoma. J. Pharm. Pharmacol., 2007, 59, 1359-1364.
28. Kunii, R.; Onishi, H.; Machida, Y. Preparation and antitumor characteristics of PLA/(PEG-PPG-PEG) nanoparticles loaded with camptothecin. Eur. J. Pharm. Biopharm., 2007, 67(1), 9-17.
29. Derakhshandeh, K.; Erfan, M.; Dadashzadeh, S. Encapsulation of 9-nitrocamptothecin, a novel anticancer drug, in biodegradable nanoparticles: factorial design, characterization and release kinetics. Eur. J. Pharm. Biopharm., 2007, 66(1), 34-41.
30. Zhang, L. Y.; Yang, M.; Wang, Q.; Li, Y.; Guo, R.; Jiang, X. Q.; Yang, C. Z.; Liu, B. R. 10-Hydroxycamptothecin loaded nanoparticles: Preparation and antitumor activity in mice. J. Control. Release, 2007, 119(2), 153-162.
31. Gao, J.; Ming, J.; He, B.; Fan, Y.; Gu, Z.; Zhang, X. Preparation and characterization of novel polymeric micelles for 9-nitro-20(S)-camptothecin delivery. Eur. J. Pharm. Sci., 2008, 34(2-3), 85-93.
32. Dadashzadeh, S.; Derakhshandeh, K.; Shirazi, F. H. 9-nitrocamptothecin polymeric nanoparticles: cytotoxicity and pharmacokinetic studies of lactone and total forms of drug in rats. Anticancer Drugs, 2008, 19(8), 805-811.
33. Chang, Y.-C.; Chu, I. M. Methoxy poly(ethylene glycol)-bpoly( valerolactone) diblock polymeric micelles for enhanced encapsulation and protection of camptothecin. Eur. Polym. J., 2008, 44(12), 3922-3930.
34. McCarron, P. A.; Marouf, W. M.; Quinn, D. J.; Fay, F.; Burden, R. E.; Olwill, S. A.; Scott, C. J. Antibody targeting of camptothecinloaded PLGA nanoparticles to tumor cells. Bioconjug. Chem., 2008, 19(8), 1561-1569.
35. Huang, Z. R.; Hua, S. C.; Yang, Y. L.; Fang, J. Y. Development and evaluation of lipid nanoparticles for camptothecin delivery: a comparison of solid lipid nanoparticles, nanostructured lipid carriers, and lipid emulsion. Acta Pharmacol. Sin., 2008, 29(9), 1094-1102.
36. Han, M.; He, C.-X.; Fang, Q.-L.; Yang, X.-C.; Diao, Y.-Y.; Xu, D.-H.; He, Q.-J.; Hu, Y.-Z.; Liang, W.-Q.; Yang, B.; Gao, J.-Q. A novel camptothecin derivative incorporated in nano-carrier induced distinguished improvement in solubility, stability and anti-tumor activity both in vitro and in vivo. Pharm. Res., 2009, 26(4), 926-935.
37. Min, K. H.; Park, K.; Kim, Y.-S.; Bae, S. M.; Lee, S.; Jo, H. G.; Park, R.-W.; Kim, I.-S.; Jeong, S. Y.; Kim, K.; Kwon, I. C. Hydrophobically modified glycol chitosan nanoparticlesencapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy. J. Control. Release, 2008, 127(3), 208-218.
38. Yang, L.; Cui, F.; Cun, D.; Tao, A.; Shi, K.; Lin, W. Preparation, characterization and biodistribution of the lactone form of 10- hydroxycamptothecin(HCPT)-loaded bovine serum albumin(BSA) nanoparticles. Int. J. Pharm., 2007, 340(1-2), 163-172.
39. Zhu, A.; Yuan, L.; Jin, W.; Dai, S.; Wang, Q.; Xue, Z.; Qin, A. Polysaccharide surface modified Fe3O4 nanoparticles for camptothecin loading and release. Acta Biomater., 2009, 5(5), 1489-1498.
40. Li, Y. C.; Dong, L.; Jia, A.; Chang, X. M.; Xue, H. Preparation of solid lipid nanoparticles loaded with traditional Chinese medicine by high-pressure homogenization. Nan Fang Yi Ke Da Xue Xue Bao, 2006, 26(5), 541-544.
41. Li, Y. C.; Dong, L.; Jia, A.; Chang, X. M.; Xue, H. Preparation and characterization of solid lipid nanoparticles loaded traditional Chinese medicine. Int. J. Biol. Macromol., 2006, 38(3-5), 296-299.
42. Xiaoyan, A.; Jun, Y.; Min, W.; Haiyue, Z.; Li, C.; Kangde, Y.; Fanglian, Y. Preparation of chitosan-gelatin scaffold containing tetrandrine-loaded nano-aggregates and its controlled release behavior. Int. J. Pharm., 2008, 350(1-2), 257-264.
43. Xiao, C.; Zhou, J.; He, Y.; Jia, H.; Zhao, L.; Zhao, N.; Lu, A. Effects of triptolide from Radix Tripterygium wilfordii (Leigongteng) on cartilage cytokines and transcription factor NFkappaB: a study on induced arthritis in rats. Chin. Med., 2009, 4(1),13.
44. Zhu, W. B.; Ou, Y. Q.; Li, Y.; Xiao, R.; Shu, M. F.; Zhou, Y. H.; Xie, J.; He, S. M.; Qiu, P. X.; Yan, G. M. A small-molecule triptolide suppresses angiogenesis and invasion of human anaplastic thyroid carcinoma cells via down-regulation of the nuclear factor-kappa B pathway. Mol. Pharmacol., 2009, 75(4), 812-819.
45. Xu, L.; Chen, H.; Xu, H.; Yang, X. Anti-tumour and immunomodulation effects of triptolide-loaded polymeric micelles. Eur. J. Pharm. Biopharm., 2008, 70(3), 741-748.
46. Xiong, F. L.; Chen, H. B.; Chang, X. L.; Yang, Y. J.; Xu, H. B.; Yang, X. L. Research progress of triptolide-loaded nanoparticles delivery systems. Conf. Proc. IEEE Eng. Med. Biol. Soc., 2005, 5, 4966-4969.
47. Feng, N.; Wu, P.; Li, Q.; Mei, Y.; Shi, S.; Yu, J.; Xu, J.; Liu, Y.; Wang, Y. Oridonin-loaded poly(epsilon-caprolactone)-poly (ethylene oxide)-poly(epsilon-caprolactone) copolymer nanoparticles: preparation, characterization, and antitumor activity on mice with transplanted hepatoma. J. Drug Target, 2008, 16(6), 479-485.
48. Zhang, D. R.; Tan, T. W.; Gao, L. Preparation of oridonin-loaded solid lipid nanoparticles and studies on them in vitro and in vivo. Nanotechnology, 2006, 17(23), 5821-5828.
49. Gao, L.; Zhang, D.; Chen, M.; Duan, C.; Dai, W.; Jia, L.; Zhao, W. Studies on pharmacokinetics and tissue distribution of oridonin nanosuspensions. Int. J. Pharm., 2008, 355(1-2), 321-327.
50. Guo, Y. M.; Zhao, J. Z.; Yu, K. F.; Liu, Y. H.; Wang, Z. C.; Zhang, H. B. Components analysis and antibacterial activity of calamine. Chem. J. Chin. Univ-Chin., 2005, 26(2), 209-212.
51. Deng, Y.; Xu, H. B.; Huang, K. X.; Yang, X. L.; Xie, C. S.; Wu, J. Size effects of realgar particles on apoptosis in a human umbilical vein endothelial cell line: ECV-304. Pharmacol. Res., 2001, 44(6), 513-518.
52. Ye, H. Q.; Gan, L.; Yang, X. L.; Xu, H. B. Membrane toxicity accounts for apoptosis induced by realgar nanoparticles in promyelocytic leukemia HL-60 cells. Bio. Trace Elem. Res., 2005, 103(2), 117-132.
53. Wang, N.; Wang, L. W.; Gou, B. D.; Zhang, T. L.; Wang, K. Realgar-induced differentiation is associated with MAPK pathways in HL-60 cells. Cell Biol. Int., 2008, 32(12), 1497-1505.
54. Wu, J. Z.; Ho, P. C. Evaluation of the in vitro activity and in vivo bioavailability of realgar nanoparticles prepared by cryo-grinding. Eur. J. Pharm. Sci., 2006, 29(1), 35-44.
55. Zhao, Q.-H.; Zhang, Y.; Liu, Y.; Wang, H.-L.; Shen, Y.-Y.; Yang, W.-J.; Wen, L.-P. Anticancer effect of realgar nanoparticles on mouse melanoma skin cancer in vivo via transdermal drug delivery. Med. Oncol., 2009.
56. Wang, X. B.; Gao, H. Y.; Hou, B. L.; Huang, J.; Xi, R. G.; Wu, L. J. Nanoparticle realgar powders induce apoptosis in U937 cells through caspase MAPK and mitochondrial pathways. Arch. Pharm. Res., 2007, 30(5), 653-658.
57. Asl, M. N.; Hosseinzadeh, H. Review of pharmacological effects of Glycyrrhiza sp and its bioactive compounds. Phytother. Res., 2008, 22(6), 709-724.
58. Fiore, C.; Eisenhut, M.; Krausse, R.; Ragazzi, E.; Pellati, D.; Armanini, D.; Bielenberg, J. Antiviral effects of Glycyrrhiza species. Phytother. Res., 2008, 22(2), 141-148.
59. Wu, Y.; Yang, W. L.; Wang, C. C.; Hu, J. H.; Fu, S. K. Chitosan nanoparticles as a novel delivery system for ammonium glycyrrhizinate. Int. J. Pharm., 2005, 295(1-2), 235-245.
60. Ke Wei Yang; Xin Ru Li; Zhuo Li Yang; Ping Zhu Li; Fei Wang; Yan Liu, Novel polyion complex micelles for liver-targeted delivery of diammonium glycyrrhizinate: In vitro and in vivo characterization. J. Biomed. Mater. Res. Part A, 2009, 88A(1), 140-148.
61. Suwantong, O.; Ruktanonchai, U.; Supaphol, P. Electrospun cellulose acetate fiber mats containing asiaticoside or Centella asiatica crude extract and the release characteristics of asiaticoside. Polymer, 2008, 49(19), 4239-4247.
62. Sikareepaisan, P.; Suksamrarn, A.; Supaphol, P. Electrospun gelatin fiber mats containing a herbal-Centella asiatica-extract and release characteristic of asiaticoside. Nanotechnology, 2008, 19(1),10.
63. Zhang, J. Q.; Liu, J.; Li, Y. L.; Jasti, B. R. Preparation and characterization of solid lipid nanoparticles containing Silibinin. Drug Deliv., 2007, 14(6), 381-387.
64. Xing, J.; Zhang, D.; Tan, T. Studies on the oridonin-loaded poly(D,L-lactic acid) nanoparticles in vitro and in vivo. Int. J. Biol. Macromol., 2007, 40(2), 153-158.
65. Hou, Z. Q.; Zhang, Z. X.; Zhang, C. X.; Huang, M. Use of natural plant exudates(Sanguis Draxonis) for sustained oral insulin delivery with dramatic reduction of glycemic effects in diabetic rats J. Control Release, 2004, 97(3), 467-475.
66. Fang, J.-Y.; Hung, C.-F.; Hua, S.-C.; Hwang, T.-L. Acoustically active perfluorocarbon nanoemulsions as drug delivery carriers for camptothecin: Drug release and cytotoxicity against cancer cells. Ultrasonics, 2009, 49(1), 39-46.
67. Mao, S. J.; Hou, S. X.; He, R.; Zhang, L. K.; Wei, D. P.; Bi, Y. Q.; Jin, H. Uptake of albumin nanoparticle surface modified with glycyrrhizin by primary cultured rat hepatocytes. World J. Gastroenterol., 2005, 11(20), 3075-3079.
68. Lin, A. H.; Liu, Y. M.; Huang, Y.; Sun, J. B.; Wu, Z. F.; Zhang, M.; Ping, Q. N. Glycyrrhizin surface-modified chitosan nanoparticles for hepatocyte-targeted delivery. Int. J. Pharm., 2008, 359(1-2), 247-253.
69. Vandenbogaerde, A. L.; Delaey, E. M.; Vantieghem, A. M.; Himpens, B. E.; Merlevede, W. J.; de Witte, P. A. Cytotoxicity and antiproliferative effect of hypericin and derivatives after photosensitization. Photochem. Photobiol., 1998, 67(1), 119-125.
70. Lenard, J.; Rabson, A.; Vanderoef, R. Photodynamic inactivation of infectivity of human-immunodeficiency-virus and other enveloped viruses using hypericin and rose-bengal - inhibition of fusion and syncytia formation. Proc. Nat. Acad. Sc. USA, 1993, 90(1), 158-162.
71. Zeisser-Labouebe, M.; Lange, N.; Gurny, R.; Delie, F. Hypericinloaded nanoparticles for the photodynamic treatment of ovarian cancer. Int. J. Pharm., 2006, 326(1-2), 174-181.
72. Zeisser-Labouebe, M.; Delie, F.; Gurny, R.; Lange, N. Benefits of nanoencapsulation for the hypercin-mediated photodetection of ovarian micrometastases. Eur. J. Pharm. Biopharm., 2009, 71(2), 207-213.
73. Su, Y. L.; Fu, Z. Y.; Quan, C. J.; Wang, W. M. In Fabrication of nano Rhizama Chuanxiong particles and determination of tetramethylpyrazine, Allerton Press Inc: 2006; S393-S397.
74. Ma, P. Y.; Fu, Z. Y.; Su, Y. L.; Ma, J. J. The nano pulverization of traditional Chinese medicine Liuwei Dihuang. J. Wuhan Univ. Technol-Mat. Sci. Edit., 2006, 21(2), 105-108.
75. Liu, J. R.; Chen, G. F.; Shih, H. N.; Kuo, P. C. Enhanced antioxidant bioactivity of Salvia miltiorrhiza(Danshen) products prepared using nanotechnology. Phytomedicine, 2008, 15(1-2), 23-30.